Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024
“Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age.”
The non-invasive prenatal testing market is projected to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.
“The services segment is expected to grow at the highest CAGR during the forecast period.”
Based on product and service, the NIPT market is segmented into products and services. The services segment is estimated to register the highest growth rate during the forecast period. The rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services are contributing to the growth of this market.
“The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.”
Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2018, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
“Asia to witness high growth during the forecast period.”
By region, the global NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a picture of the global NIPT market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, and region. The NIPT products market is segmented on the basis of method and end user. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NIPT market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.
The non-invasive prenatal testing market is projected to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.
“The services segment is expected to grow at the highest CAGR during the forecast period.”
Based on product and service, the NIPT market is segmented into products and services. The services segment is estimated to register the highest growth rate during the forecast period. The rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services are contributing to the growth of this market.
“The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.”
Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2018, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
“Asia to witness high growth during the forecast period.”
By region, the global NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), D-level (34%), and Others (36%)
- By Region: North America (40%), Europe (28%), Asia (20%), and RoW (12%)
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- GE Healthcare (US)
- BGI (China)
- Agilent Technologies, Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- PerkinElmer Inc. (US)
- Laboratory Corporation of America Holdings (LabCorp) (US)
- Natera, Inc. (US)
- Yourgene Health (UK)
This report provides a picture of the global NIPT market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, and region. The NIPT products market is segmented on the basis of method and end user. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NIPT market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NON-INVASIVE PRENATAL TESTING: MARKET OVERVIEW
4.2 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (2019–2024)
4.3 NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY METHOD & REGION (2018)
4.4 NON-INVASIVE PRENATAL TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 High risk of chromosomal abnormalities with increasing maternal age
5.1.1.2 Growing preference for noninvasive techniques over invasive methods
5.1.1.3 Improving reimbursement scenario for NIPT
5.1.1.4 Programs focusing on increasing the awareness of NIPT
5.1.2 OPPORTUNITIES
5.1.2.1 Untapped emerging markets
5.1.3 CHALLENGES
5.1.3.1 Reliability of test results, especially in obese women
5.1.3.2 Lack of skilled professionals
6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 CONSUMABLES
6.2.1.1 Assay kits & reagents
6.2.1.1.1 North America is the largest market for assay kits & reagents segments
6.2.1.2 Disposables
6.2.1.2.1 Use of disposables to avoid contamination is one of the major growth factors for this segment
6.2.2 INSTRUMENTS
6.2.2.1 Ultrasound devices
6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety has driven market growth
6.2.2.2 Next-generation sequencing systems
6.2.2.2.1 NGS systems have found rising use in NIPT
6.2.2.3 Polymerase chain reaction instruments
6.2.2.3.1 Increasing research in the field of prenatal genetic testing is expected to boost market growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of chips and short processing times have supported the use of microarrays
6.2.2.5 Other instruments
6.3 SERVICES
6.3.1 NORTH AMERICA SHOWS THE HIGHEST DEMAND FOR TESTING SERVICES
7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD
7.1 INTRODUCTION
7.2 ULTRASOUND DETECTION
7.2.1 ULTRASOUND DETECTION SEGMENT DOMINATES THE NIPT PRODUCTS MARKET
7.3 BIOCHEMICAL SCREENING TESTS
7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS & INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
7.4 CELL-FREE DNA IN MATERNAL PLASMA TESTS
7.4.1 CELL-FREE DNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 TRISOMY
8.2.1 TRISOMY FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
8.3 MICRODELETION SYNDROME
8.3.1 HIGH INCIDENCE OF MICRODELETION SYNDROME IS A KEY FACTOR DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
8.4 OTHER APPLICATIONS
9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NIPT PRODUCTS AMONG DIAGNOSTIC LABS
9.3 HOSPITALS
9.3.1 NORTH AMERICA HOLDS THE MAJOR SHARE OF THIS END-USER SEGMENT
10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 High number of babies born with chromosomal syndromes is a major factor driving the demand for non-invasive prenatal testing in the US
10.2.2 CANADA
10.2.2.1 Unfavorable reimbursement scenario for non-invasive prenatal testing is a key challenge for market growth in Canada
10.3 EUROPE
10.3.1 FRANCE
10.3.1.1 Favorable insurance coverage for prenatal testing to increase the adoption of NIPT in France
10.3.2 UK
10.3.2.1 High incidence of genetic abnormalities to increase the demand for prenatal testing procedures in the UK
10.3.3 GERMANY
10.3.3.1 Increasing healthcare spending—a major factor contributing to market growth in Germany
10.3.4 REST OF EUROPE
10.4 ASIA
10.4.1 HIGH COST OF NIPT PRODUCTS IS A MAJOR FACTOR LIMITING MARKET GROWTH IN ASIA DURING THE FORECAST PERIOD
10.5 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET PLAYER RANKING
11.3 COMPETITIVE LEADERSHIP MAPPING – PRODUCT MARKET
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING PLAYERS
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT & SERVICES LAUNCHES
11.4.2 EXPANSIONS
11.4.3 ACQUISITIONS
11.4.4 OTHER STRATEGIES
12 COMPANY PROFILE
(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*
12.1 ILLUMINA, INC.
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
12.4 PERKINELMER, INC.
12.5 AGILENT TECHNOLOGIES, INC.
12.6 BEIJING GENOMICS INSTITUTE
12.7 F. HOFFMAN-LA ROCHE LTD.
12.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
12.9 NATERA, INC.
12.10 YOURGENE HEALTH
* Business Overview, Products and Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NON-INVASIVE PRENATAL TESTING: MARKET OVERVIEW
4.2 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (2019–2024)
4.3 NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY METHOD & REGION (2018)
4.4 NON-INVASIVE PRENATAL TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 High risk of chromosomal abnormalities with increasing maternal age
5.1.1.2 Growing preference for noninvasive techniques over invasive methods
5.1.1.3 Improving reimbursement scenario for NIPT
5.1.1.4 Programs focusing on increasing the awareness of NIPT
5.1.2 OPPORTUNITIES
5.1.2.1 Untapped emerging markets
5.1.3 CHALLENGES
5.1.3.1 Reliability of test results, especially in obese women
5.1.3.2 Lack of skilled professionals
6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 CONSUMABLES
6.2.1.1 Assay kits & reagents
6.2.1.1.1 North America is the largest market for assay kits & reagents segments
6.2.1.2 Disposables
6.2.1.2.1 Use of disposables to avoid contamination is one of the major growth factors for this segment
6.2.2 INSTRUMENTS
6.2.2.1 Ultrasound devices
6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety has driven market growth
6.2.2.2 Next-generation sequencing systems
6.2.2.2.1 NGS systems have found rising use in NIPT
6.2.2.3 Polymerase chain reaction instruments
6.2.2.3.1 Increasing research in the field of prenatal genetic testing is expected to boost market growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of chips and short processing times have supported the use of microarrays
6.2.2.5 Other instruments
6.3 SERVICES
6.3.1 NORTH AMERICA SHOWS THE HIGHEST DEMAND FOR TESTING SERVICES
7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD
7.1 INTRODUCTION
7.2 ULTRASOUND DETECTION
7.2.1 ULTRASOUND DETECTION SEGMENT DOMINATES THE NIPT PRODUCTS MARKET
7.3 BIOCHEMICAL SCREENING TESTS
7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS & INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
7.4 CELL-FREE DNA IN MATERNAL PLASMA TESTS
7.4.1 CELL-FREE DNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 TRISOMY
8.2.1 TRISOMY FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
8.3 MICRODELETION SYNDROME
8.3.1 HIGH INCIDENCE OF MICRODELETION SYNDROME IS A KEY FACTOR DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
8.4 OTHER APPLICATIONS
9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NIPT PRODUCTS AMONG DIAGNOSTIC LABS
9.3 HOSPITALS
9.3.1 NORTH AMERICA HOLDS THE MAJOR SHARE OF THIS END-USER SEGMENT
10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 High number of babies born with chromosomal syndromes is a major factor driving the demand for non-invasive prenatal testing in the US
10.2.2 CANADA
10.2.2.1 Unfavorable reimbursement scenario for non-invasive prenatal testing is a key challenge for market growth in Canada
10.3 EUROPE
10.3.1 FRANCE
10.3.1.1 Favorable insurance coverage for prenatal testing to increase the adoption of NIPT in France
10.3.2 UK
10.3.2.1 High incidence of genetic abnormalities to increase the demand for prenatal testing procedures in the UK
10.3.3 GERMANY
10.3.3.1 Increasing healthcare spending—a major factor contributing to market growth in Germany
10.3.4 REST OF EUROPE
10.4 ASIA
10.4.1 HIGH COST OF NIPT PRODUCTS IS A MAJOR FACTOR LIMITING MARKET GROWTH IN ASIA DURING THE FORECAST PERIOD
10.5 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET PLAYER RANKING
11.3 COMPETITIVE LEADERSHIP MAPPING – PRODUCT MARKET
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING PLAYERS
11.4 COMPETITIVE SITUATION AND TRENDS
11.4.1 PRODUCT & SERVICES LAUNCHES
11.4.2 EXPANSIONS
11.4.3 ACQUISITIONS
11.4.4 OTHER STRATEGIES
12 COMPANY PROFILE
(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*
12.1 ILLUMINA, INC.
12.2 THERMO FISHER SCIENTIFIC, INC.
12.3 GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
12.4 PERKINELMER, INC.
12.5 AGILENT TECHNOLOGIES, INC.
12.6 BEIJING GENOMICS INSTITUTE
12.7 F. HOFFMAN-LA ROCHE LTD.
12.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
12.9 NATERA, INC.
12.10 YOURGENE HEALTH
* Business Overview, Products and Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 INCIDENCE RATE OF TRISOMY
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE (GLOBALLY)
TABLE 3 COMPARISON OF NON-INVASIVE AND INVASIVE PRENATAL TESTING
TABLE 4 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
TABLE 5 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
TABLE 6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 NIPT CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 10 NIPT CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 NIPT ASSAY KITS AND REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 NIPT DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NIPT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 16 NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 EUROPE: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 NIPT ULTRASOUND DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 NIPT NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 NIPT PCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 NIPT MICROARRAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 OTHER NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NIPT SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 26 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 35 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY REGION, 2017–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42 NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 43 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 45 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 49 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY REGION, 2017–2024 (USD MILLION)
TABLE 50 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 52 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 53 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 54 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 55 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 57 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 59 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 60 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 61 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 63 US: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 67 CANADA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 68 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 69 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 70 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 71 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 EUROPE: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 EUROPE: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 75 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 76 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 77 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 79 FRANCE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 80 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 81 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 83 UK: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 84 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 85 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 87 GERMANY: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 88 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 89 THE TABLE BELOW MENTIONS THE MEAN MATERNAL AGE AT FIRST BIRTH IN ROE COUNTRIES:
TABLE 90 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 92 ROE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 93 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 94 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 95 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 ASIA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ASIA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 99 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 100 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 101 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 102 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 103 ROW: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 104 ROW: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 106 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 107 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 108 PRODUCT AND SERVICE LAUNCHES, 2016–2018
TABLE 109 EXPANSIONS, 2016–2018
TABLE 110 ACQUISITIONS, 2016–2018
TABLE 111 OTHER STRATEGIES, 2016–2018
TABLE 112 EXCHANGE RATE (USED FOR THE CONVERSION OF GBP TO USD)
TABLE 1 INCIDENCE RATE OF TRISOMY
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE (GLOBALLY)
TABLE 3 COMPARISON OF NON-INVASIVE AND INVASIVE PRENATAL TESTING
TABLE 4 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
TABLE 5 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
TABLE 6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 NIPT CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 10 NIPT CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 NORTH AMERICA: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 EUROPE: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 NIPT ASSAY KITS AND REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 NIPT DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15 NIPT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 16 NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 EUROPE: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 NIPT ULTRASOUND DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 NIPT NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21 NIPT PCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22 NIPT MICROARRAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 OTHER NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 24 NIPT SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 25 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 26 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY REGION, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 32 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 35 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY REGION, 2017–2024 (USD MILLION)
TABLE 37 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42 NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 43 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 45 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 49 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY REGION, 2017–2024 (USD MILLION)
TABLE 50 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 52 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 53 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 54 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 55 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 56 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 57 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 58 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 59 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 60 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 61 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 62 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 63 US: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 67 CANADA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 68 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 69 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 70 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 71 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 72 EUROPE: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 EUROPE: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 74 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 75 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 76 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 77 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 78 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 79 FRANCE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 80 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 81 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 82 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 83 UK: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 84 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 85 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 87 GERMANY: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 88 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 89 THE TABLE BELOW MENTIONS THE MEAN MATERNAL AGE AT FIRST BIRTH IN ROE COUNTRIES:
TABLE 90 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 91 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 92 ROE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 93 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 94 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 95 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 ASIA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97 ASIA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 99 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 100 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 101 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 102 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 103 ROW: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 104 ROW: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 106 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 107 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 108 PRODUCT AND SERVICE LAUNCHES, 2016–2018
TABLE 109 EXPANSIONS, 2016–2018
TABLE 110 ACQUISITIONS, 2016–2018
TABLE 111 OTHER STRATEGIES, 2016–2018
TABLE 112 EXCHANGE RATE (USED FOR THE CONVERSION OF GBP TO USD)
LIST OF FIGURES
FIGURE 1 NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
FIGURE 10 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 11 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 13 HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE IS A MAJOR FACTOR DRIVING THE ADOPTION OF NON-INVASIVE PRENATAL TESTING
FIGURE 14 TRISOMY IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
FIGURE 15 ULTRASOUND DETECTION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
FIGURE 16 THE NIPT MARKET IN ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2019–2024)
FIGURE 17 NIPT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
FIGURE 19 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2016-2018
FIGURE 21 GLOBAL NON-INVASIVE PRENATAL TESTING MARKET PLAYER RANKING FOR PRODUCT, 2018
FIGURE 22 NIPT MARKET – PRODUCT MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 23 ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
FIGURE 25 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 26 PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
FIGURE 27 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2018)
FIGURE 29 LABCORP: COMPANY SNAPSHOT (2018)
FIGURE 30 NATERA, INC.: COMPANY SNAPSHOT (2018)
FIGURE 31 YOURGENE HEALTH.: COMPANY SNAPSHOT (2018)
FIGURE 1 NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
FIGURE 10 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 11 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 13 HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE IS A MAJOR FACTOR DRIVING THE ADOPTION OF NON-INVASIVE PRENATAL TESTING
FIGURE 14 TRISOMY IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
FIGURE 15 ULTRASOUND DETECTION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
FIGURE 16 THE NIPT MARKET IN ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2019–2024)
FIGURE 17 NIPT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
FIGURE 19 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2016-2018
FIGURE 21 GLOBAL NON-INVASIVE PRENATAL TESTING MARKET PLAYER RANKING FOR PRODUCT, 2018
FIGURE 22 NIPT MARKET – PRODUCT MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 23 ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
FIGURE 25 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 26 PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
FIGURE 27 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2018)
FIGURE 29 LABCORP: COMPANY SNAPSHOT (2018)
FIGURE 30 NATERA, INC.: COMPANY SNAPSHOT (2018)
FIGURE 31 YOURGENE HEALTH.: COMPANY SNAPSHOT (2018)
